Squamous-cell carcinoma of the skin

A Wysong - New England Journal of Medicine, 2023 - Mass Medical Soc
Squamous-Cell Carcinoma of the Skin | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Recent advances in the diagnosis and management of high-risk cutaneous squamous cell carcinoma

C Dessinioti, AJ Stratigos - Cancers, 2022 - mdpi.com
Simple Summary Cutaneous squamous cell carcinoma (cSCC) is the second most common
skin cancer. Although most cSCCs are effectively treated with surgery, there are some …

[HTML][HTML] European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023

AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European Journal of …, 2023 - Elsevier
Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
white populations, accounting for 20% of all cutaneous malignancies. Overall, cSCC mostly …

Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model

B Rentroia-Pacheco, S Tokez, EM Bramer… - …, 2023 - thelancet.com
Background Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer,
affecting more than 2 million people worldwide yearly and metastasising in 2–5% of …

[HTML][HTML] HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway

M Jia, KY Zhou, LJ Deng, S Fang - American Journal of Cancer …, 2023 - ncbi.nlm.nih.gov
Cutaneous squamous cell carcinoma (cSCC) is a common type of nonmelanoma skin
cancer with a very high incidence. Heat shock proteins (HSPs) are involved in abnormal …

Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis

J Wang, CA Harwood, E Bailey… - Journal of the American …, 2023 - Elsevier
Background Metastasis of cutaneous squamous cell carcinoma (cSCC) is uncommon.
Current staging methods are reported to have sub-optimal performances in metastasis …

Long‐term outcomes, quality of life, and costs of treatment modalities for T1–T2 lip carcinomas

KS van Hof, M Wakkee, A Sewnaik… - Oral …, 2024 - Wiley Online Library
Purpose Early stage lip squamous cell carcinoma (lip SCC) can be treated with conventional
excision, Mohs micrographic surgery (MMS), or brachytherapy. The aim of this retrospective …

Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case–Control Study

A Paganelli, M Zaffonato, B Donati, F Torricelli… - Cancers, 2024 - mdpi.com
Simple Summary This study investigates the characteristics of metastatic cutaneous
squamous cell carcinoma (cSCC) to improve patient risk stratification. By comparing patients …

Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options

ZG Attal, W Shalata, A Soklakova, L Tourkey, S Shalata… - Biomedicines, 2024 - mdpi.com
Non-melanoma skin cancers (NMSC) form the majority of skin cancers, with basal cell
carcinoma (BCC) being the most common and cutaneous squamous cell carcinoma (cSCC) …

Patient-initiated follow-up for high-risk cutaneous squamous cell carcinoma. How we do it and two years of outcome data

SM Abdul Gafoor, S Robinson… - Clinical and …, 2024 - academic.oup.com
Why do we follow-up patients with high-risk cutaneous squamous-cell carcinomas (cSCC)?
Current guidance suggests we offer post-treatment follow-up appointments at regular …